Dual-dose Aprepitant to Reduce Postoperative Nausea and Vomiting After Laparoscopic Bariatric Surgery.

Clinical trial NCT05189756 · TERMINATED

Trial details

NCT number: NCT05189756
Sponsor: Insel Gruppe AG, University Hospital Bern
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Postoperative Nausea and Vomiting Bariatric Surgery

Start date: 2022-03-17
Primary completion: 2025-02-20
Enrollment: 71

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.